RAD December 2021 Conference Abstracts and Posters

All accepted abstracts will be published in the British Journal of Dermatology.

562 - The Psychosocial Burden Associated With and Effective Treatment Approach for Atopic Dermatitis: A Literature Review

Hira Ghani BA, Marielle Jamgochian MBS, Amy Pappert MD, Raphia Rahman MBS, Stefanie Cubelli


573 - Oral Difelikefalin Reduces Pruritus in Atopic Dermatitis

Brian S. Kim, MD, MTR; Masato Tamari, MD, PhD; Lydia Zamidar, BS; Kristine Nograles, MD; Catherine Munera, PhD; Joana Goncalves, MD; Emma Guttman-Yassky, MD, PhD; Mark Lebwohl, MD


575 - Tapinarof Cream 1% Once Daily for the Treatment of Moderate to Severe Atopic Dermatitis in Children and Adults: the Pivotal Phase 3 ADORING Clinical Program

Lawrence F. Eichenfield, MD, Jonathan I. Silverberg, MD, PhD, MPH, Robert Bissonnette, MD, Anna M. Tallman, PharmD, Philip M. Brown, MD, JD, David S. Rubenstein, MD, PhD, Stephen C. Piscitelli, PharmD, John E. Jett, PhD


579 - Validation of a Spanish version of the ADCT (Atopic Dermatitis Control Tool) questionnaire for the assessment of disease control in patients with atopic dermatitis

Angles Maria Valeria, Caviedes Mariana Paula, Luna Paula Carolina, Terrasa Sergio, Vazquez Peña Fernando, Cristina Echeverría, Larralde Margarita, Mazzuoccolo Luis Daniel


583 - Divergent Paths: The Influence of Pediatric Atopic Dermatitis on Caregiver and Family Life Decisions

Korey Capozza, Jessica Lang, Alan Schwartz, Andrew Y Finlay


584 - Short-Term Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis Stratified by Age

Andrew Alexis, MD, MPH; Mette Deleuran, MD, DMSc; Jonathan I. Silverberg, MD, PhD, MPH; Melinda Gooderham, MSc, MD, FRCPC; Susan L. Johnson, MD, MS; Gary Chan, PharmD; Pinaki Biswas, PhD; Melissa Watkins, PhD


588 - Rates of Malignancies Among Patients with Moderate and Severe Atopic Dermatitis: A Retrospective Cohort Study

Monique M. Hedderson, Maryam M. Asgari, Fei Xu, Charles P. Quesenberry, Sneha Sridhar, Jamie Geier, Adina R. Lemeshow


596 - Dupilumab Monotherapy Provides Long-Term Control and Prevents Flares in Adults With Moderate-to-Severe Atopic Dermatitis Optimally Responding at Week 16

Andreas Wollenberg, Diamant Thaçi, Eric L. Simpson, Robert Bissonnette, Amy Praestgaard, Gerald Wilson, Ana B. Rossi


597 - Patient Well-being and Perception of Treatment Effect With Long-Term Dupilumab Monotherapy in Adults With Moderate-to-Severe Atopic Dermatitis

Eric L. Simpson, Stefan Beissert, Lisa A. Beck, Haixin Zhang, Kimberly Aamodt, Ana B. Rossi


598 - Dupilumab Provides Long-Term Efficacy Over 2.5 Years in Adults With Moderate-to-Severe Atopic Dermatitis

Lisa A. Beck, Robert Bissonnette, Andreas Wollenberg, Eric L. Simpson, Diamant Thaçi, Amy Praestgaard, Kimberly Aamodt, Ana B. Rossi


Page 1 of 7
Results 1 - 10 of 66
© 2022 The Foundation for Dermatology Education.
The Foundation for Dermatology Education is a registered 501(c)(3) nonprofit organization located in Chicago, IL.